Bruce Booth - Insider Trading & Ownership

Location
890 Winter Street, Suite 320, Waltham, MA
Summary
The estimated net worth of Bruce Booth is at least $135M dollars as of October 7, 2025. Bruce Booth is the Director of Sionna Therapeutics, Inc. and owns shares of Sionna Therapeutics, Inc. (SION) stock worth about $107M. Bruce Booth is the Director of Kymera Therapeutics, Inc. and owns shares of Kymera Therapeutics, Inc. (KYMR) stock worth about $28.4M. Bruce Booth is the Director of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $138K.
Signature
/s/ Ommer Chohan, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Bruce Booth

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SION Sionna Therapeutics, Inc. Director $107M -$3.85M -3.48% Oct 3, 2025
KYMR Kymera Therapeutics, Inc. Director $28.4M Jun 25, 2025
VIGL Vigil Neuroscience, Inc. Director $138K Aug 5, 2025
TECX Tectonic Therapeutic, Inc. Director Jun 6, 2023
DNTH Dianthus Therapeutics, Inc. /DE/ Director Jun 28, 2022

Insider Transactions Reported by Bruce Booth:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.